InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) EPS (Basic) (2016 - 2026)

InflaRx's (IFRX) quarterly EPS (Basic) came in at -$0.11 in Q2 2026, up 54.54% year-over-year from -$0.07 in Q2 2025, and up 9.3% quarter-over-quarter from -$0.12 in Q1 2026.

Analysis

InflaRx (IFRX) EPS (Basic) (2016 - 2026) Analysis & Trends

InflaRx has disclosed EPS (Basic) across 11 years of filings, most recently posting -$0.11 for Q2 2026.

  • In Q2 2026, EPS (Basic) rose 54.54% year-over-year to -$0.11; the TTM figure through Jun 2026 stood at -$0.6 (up 64.35% YoY), while the FY2025 annual figure was -$0.77, up 8.31% from the prior year.
  • EPS (Basic) came in at -$0.11 for Q2 2026 at InflaRx, up from -$0.12 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $14046.6 in Q4 2022 to a low of -$0.95 in Q4 2024.
  • Average EPS (Basic) over 5 years is $780.09, with a median of -$0.23 recorded in 2024.
  • Year-over-year, EPS (Basic) surged 367.49% in 2022 and sank 745.33% in 2023.
  • Over 5 years, EPS (Basic) stood at $14046.6 in 2022, then plunged by 100.01% to -$0.86 in 2023, then slipped by 10.6% to -$0.95 in 2024, then surged by 77.3% to -$0.22 in 2025, then surged by 49.75% to -$0.11 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were -$0.11 in Q2 2026, -$0.12 in Q1 2026, and -$0.22 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 4.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -8.44
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 4.34
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 12.62
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 7.70
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -1.96
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.23
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.66
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -0.40
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -0.11
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.11
Mar 31, 2026 -0.12
Dec 31, 2025 -0.22
Sep 30, 2025 -0.18
Jun 30, 2025 -0.24
Mar 31, 2025 -0.22
Dec 31, 2024 -0.95
Sep 30, 2024 -0.29
Jun 30, 2024 -0.28
Mar 31, 2024 -0.23
Dec 31, 2023 -0.86
Sep 30, 2023 -0.25
Jun 30, 2023 -0.22
Mar 31, 2023 -0.25
Dec 31, 2022 14,046.59
Sep 30, 2022 -0.20
Jun 30, 2022 -0.03
Mar 31, 2022 -0.40
Dec 31, 2021 3,004.70
Sep 30, 2021 -0.55